Literature DB >> 2649690

Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region.

P Pontisso1, M A Petit, M J Bankowski, M E Peeples.   

Abstract

Hepatitis B virus particles contain three related viral envelope proteins, the small, middle, and large S (surface) proteins. All three proteins contain the small S amino acid sequence at their carboxyl terminus. It is not clear which of these S proteins functions as the viral attachment protein, binding to a target cell receptor and initiating infection. In this report, recombinant hepatitis B surface antigen (rHBsAg) particles, which contain only virus envelope proteins, were radioactively labeled, and their attachment to human liver membranes was examined. Only the rHBsAg particles containing the large S protein were capable of directly attaching to liver plasma membranes. The attachment was saturable and could be prevented by competition with unlabeled particles or by a monoclonal antibody specific for the large S protein. In the presence of polymerized human serum albumin, both large and middle S protein-containing rHBsAg particles were capable of attaching to the liver plasma membranes. Small S protein-containing rHBsAg particles were not able to attach even in the presence of polymerized human serum albumin. These results indicate that the large S protein may be the viral attachment protein for hepatocytes, binding directly to liver plasma membranes by its unique amino-terminal (pre-S1) sequence. These results also indicate that polymerized human serum albumin or a similar molecule could act as an intermediate receptor, attaching to liver plasma membranes and to the amino acid sequence (pre-S2) shared by the middle and large S proteins but not contained in the small S protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649690      PMCID: PMC250612     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen.

Authors:  D L Peterson; I M Roberts; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

2.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.

Authors:  D C Wiley; I A Wilson; J J Skehel
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

3.  Early events in duck hepatitis B virus infection. Sequential appearance of viral deoxyribonucleic acid in the liver, pancreas, kidney, and spleen.

Authors:  M Tagawa; M Omata; O Yokosuka; K Uchiumi; F Imazeki; K Okuda
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

4.  Receptors for polymerized albumin on liver cells.

Authors:  R Lenkei; D Onica; V Ghetie
Journal:  Experientia       Date:  1977-08-15

5.  Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay.

Authors:  B G Hansson; R H Purcell
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

6.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

7.  Duck hepatitis B virus is tropic for exocrine cells of the pancreas.

Authors:  M S Halpern; J Egan; S B McMahon; D L Ewert
Journal:  Virology       Date:  1985-10-15       Impact factor: 3.616

8.  Identification and localization of pre-s-encoded polypeptides from woodchuck and ground squirrel hepatitis viruses.

Authors:  E Schaeffer; R L Snyder; J J Sninsky
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

9.  The Vero cell receptor for the hepatitis B virus small S protein is a sialoglycoprotein.

Authors:  K Komai; M Kaplan; M E Peeples
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

10.  Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection.

Authors:  A Alberti; S Diana; G H Sculard; A L Eddleston; R Williams
Journal:  Br Med J       Date:  1978-10-14
View more
  41 in total

1.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 2.  Nature and display of hepatitis B virus envelope proteins and the humoral immune response.

Authors:  A Alberti; W H Gerlich; K H Heermann; P Pontisso
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Study on hepatitis B virus pre-S/S gene mutations of renal tissues in children with hepatitis B virus-associated membranous nephropathy.

Authors:  Se Eun Kim; Yeong Hong Park; Woo Yeong Chung
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

Review 4.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells.

Authors:  Cecilia Johansson; Mari Jonsson; Marko Marttila; David Persson; Xiao-Long Fan; Johan Skog; Lars Frängsmyr; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  Autopresentation of hepatitis B virus envelope antigens by T cells.

Authors:  C Ferrari; M Pilli; A Penna; A Bertoletti; A Valli; A Cavalli; G Pasetti; F Fiaccadori
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Spontaneous development of anti-hepatitis B virus envelope (anti-idiotypic) antibodies in animals immunized with human liver endonexin II or with the F(ab')2 fragment of anti-human liver endonexin II immunoglobulin G: evidence for a receptor-ligand-like relationship between small hepatitis B surface antigen and endonexin II.

Authors:  K Hertogs; E Depla; T Crabbé; W De Bruin; W Leenders; H Moshage; S H Yap
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 8.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

9.  Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.

Authors:  U Klingmüller; H Schaller
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 10.  Virological and serological aspects of hepatitis B and the delta agent.

Authors:  G Hess
Journal:  Gut       Date:  1993       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.